What is the optimum systemic treatment for advanced/metastatic renal cell carcinoma of favourable, intermediate and poor risk, respectively? A systematic review and network meta-an... by Guanghui Cao, Xiaoqiang Wu, Zhiwei Wang, Xiangyong Tian, Chan Zhang, Xuan Wu, Haotian Zhang, Gaopeng Jing, Tianzhong Yan

Get full text